Hormonal homeostasis in women of reproductive age with adenomyosis
Бічна панель сторінки статті
Основний зміст сторінки статті
Анотація
The problem of adenomyosis is particularly relevant for patients of reproductive age, as it is accompanied by the significant disturbances of menstrual and generative functions. The article presents the results of studying the condition of the hypothalamic-pituitary-ovarian system in women of reproductive age with adenomyosis.
The objective: to study the state of the hypothalamic-pituitary-ovarian system in women of reproductive age with benign endometrial and myometrial pathology.
Materials and methods. The main group included 120 women of reproductive age with benign endometrial and myometrial pathology (adenomyosis, endometrial hyperplasia and combined pathology), and the control group included 40 healthy women without gynecological pathology. The functional state of the hypothalamic-pituitary-ovarian system was evaluated by the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), estradiol (E2) and progesterone (P) in blood serum in different phases of the menstrual cycle.
Results. In women with adenomyosis, endometrial hyperplasia and combined pathology, there is hyperproduction of gonadotropic hormones with an increase of their secretion level compared to a group of healthy women: the average concentration of FSH, regardless of the phase of the menstrual cycle, increased by 1.9 times (p<0.05), LH – 2.2 times, PRL – 2 times, which indicates the presence of hyperprolactinemia. Both in the I and II phases of the menstrual cycle, the occurrence of additional FSH and LH peaks from basal hormone secretion was determined in patients of the main group, which reached the level of hormone concentration in the ovulatory peak. In the patients of the main group, hyperestrogenemia during the entire menstrual cycle and hypoprogesteronemia were detected. The expression of hormonal shifts depended on gynecological pathology (adenomyosis, endometrial hyperplasia and combined pathology) and the functional state of the woman.
Conclusions. The indicators of gonadotropic and prolactin-stimulating activity of the pituitary gland in women with benign uterine pathology confirm the participation of FSH, LH and prolactin in the complex processes of regulation of the reproductive system.
Блок інформації про статтю
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Автори зберігають авторське право, а також надають журналу право першого опублікування оригінальних наукових статей на умовах ліцензії Creative Commons Attribution 4.0 International License, що дозволяє іншим розповсюджувати роботу з визнанням авторства твору та першої публікації в цьому журналі.
Посилання
Makagonov IO, Vergun AR, Soldatenko OYa, Vergun OM. Before nutritional therapy for adenomyosis in women of fertile age: the effectiveness of dienogest in relation to progesterone. Internauka Journal of Sciences. 2017;15(1):16-9.
Benyuk VO, Vinyarsky Yam, Goncharenko VM, Kurochka VV. Modern aspects of diagnosing hyperplastic endometrial processes in women of reproductive age. Tauride Medical and Biological Bulletin. 2012;58(2):20-2.
Kianpour M, Nematbakhsh M, Ahmadi SM, Jafarzadeh M, Hajjarian M, Pezeshki Z, et al. Serum and peritoneal fluid levels of vascular endothelial growth factor in women with endometriosis. Int J Fertil Steril. 2013;7(2):96-9.
Mu L, Ma YY. Expression of focal adhesion kinase in endometrial stromal cells of women with endometriosis was adjusted by ovarian steroid hormones. Int J Clin Exp Pathol. 2015;8(2):1810-5. 25973072
Shcherbina M, Chehunova A. State of the cytokine profile in patients with adenomyosis. Neonatol, surgery and perinatal med. 2022;12(1(43):43-9. doi: 10.24061/2413-4260.XII.1.43.2022.8.
Altibaeva DM, Kurochka VV, Petrenko TG. Peculiarities of hormonal homeostasis in adenomyosis in combination with hyperplastic processes of the endometrium in women of reproductive age. Coll. of Sciences of the Association of Obstetricians and Gynecologists of Ukraine. 2016:17-20.
Abrao MS, Muzii L, Marana R. Anatomical causes of female infertility and their management. Int J Gynaecol Obstet. 2013;123(Suppl 2):18-24. doi: 10.1016/j.ijgo.2013.09.008.
Sayer-Jones K, Sherman KA. «My body…tends to betray me sometimes»: a Qualitative Analysis of Affective and Perceptual Body Image in Individuals Living with Endometriosis. Int J Behav Med. 2022:1-12. doi: 10.1007/s12529-022-10118-1.
Malanchuk LM, Martyniuk VM. The immunopathogenetic role of interleukin 6, 8 and tumor necrosis factor-alpha in the development of adenomyosis. Achievements of clinical and experimental medicine. 2015;(2-3):99-100.
Bahall V, De Barry L, Singh K. Thoracic endometriosis masquerading as Meigs’ syndrome in a young woman: A case report and literature review. Case Rep Womens Health. 2022;36:e00452. doi: 10.1016/j.crwh.2022.e00452.
Habib N, Buzzaccarini G, Centini G, Moawad GN, Ceccaldi PF, Gitas G, Alkatout I, Gullo G, Terzic S, Sleiman Z. Impact of lifestyle and diet on endometriosis: a fresh look to a busy corner. Prz Menopauzalny. 2022;21(2):124-32. doi: 10.5114/pm.2022.116437.
Nowakowska A, Kwas K, Fornalczyk A, Wilczyński J, Szubert M. Correlation between Endometriosis and Selected Allergic and Autoimmune Diseases and Eating Habits. Medicina (Kaunas). 2022;58(8):1038. doi: 10.3390/medicina58081038.
Benyuk VO, Altibaeva DM, Honcharenko VM, Kurochka VV. The role of immune mechanisms in the development of benign pathology of the uterus. Women’s health. 2016;(5):30-2.
Kuryk OG, Kalenska OV. Immunohistochemical study of hormonal activity of ectopic and eutopic endometrium in adenomyosis. Scientific journals of the Ministry of Health of Ukraine. 2014;(1):100-05.
Nodler JL, Harris HR, Chavarro JE, Frazier AL, Missmer SA. Dairy consumption during adolescence and endometriosis risk. Am J Obstet Gynecol. 2020;222(3):257.e1-257.e16. doi: 10.1016/j.ajog.2019.09.010.
Kurochka VV, Benyuk VO, Manzhula LV. Immunohistochemical study of estrogen and progesterone receptors in ectopic and eutopic endometrium in adenomyosis and retrocervical endometriosis. Current problem clinic prevention med. 2018,2(1):23-7.
Zervou MI, Vlachakis D, Papageorgiou L, Eliopoulos E, Goulielmos GN. Increased risk of rheumatoid arthritis in patients with endometriosis: Genetic aspects. Rheumatol. 2022;61(11):4252-62. doi: 10.1093/rheumatology/keac143.
Chen SF, Yang YC, Hsu CY, Shen YC. Risk of Rheumatoid Arthritis in Patients with Endometriosis: A Nationwide Population-Based Cohort Study. J. Women’s Health. 2021;30:160-4. doi: 10.1089/jwh.2020.8431.
Zaporozhchenko MB, Sydorenko AV. Effectiveness of the proposed comprehensive step-by-step personalized therapy in women of reproductive age with the combined pathology of the uterus-leiomyoma and adenomyosis. Women’s health. 2019;1(137):114-20.
PotapovVO, IvakhV I. Strategy for the prevention of recurrences of uterine leiomyoma in combination with adenomyosis after organ-preserving operations in women of reproductive age. Reprod Endocrinol. 2019;49 (5):16-21.
Elsherbini M, Koga K, Maki E, Kumasawa K, Satake E, Taguchi A, et al. Impact of Chronic Exposure to Endometriosis on Perinatal Outcomes: Establishment of a Mouse Model. Biomedicines. 2022;10(10):2627. doi: 10.3390/biomedicines10102627.
Yuk JS, Shin JS, Shin JY, Oh E, Kim H, Park WI. Nickel Allergy Is a Risk Factor for Endometriosis: An 11-Year Population-Based Nested Case-Control Study. PLoS ONE. 2015;10:e0139388. doi: 10.1371/journal.pone.0139388.
Pencovich N, Luk J, Hantisteanu S, Hornstein MD, Fainaru O. The development of endometriosis in a murine model is dependent on the presence of dendritic cells. Reprod Biomed. 2014;28(4):515-21. doi: 10.1016/j.rbmo.2013.12.011.
Ashrafi M, Jahangiri N, Sadatmahalleh SJ, Aliani F, Akhoond M. Diet and The Risk of Endometriosis in Iranian Women: A Case-Control Study. Int J Fertil Steril. 2020;14(3):193-200. doi: 10.22074/IJFS.2020.44378
Peng Y, Su S, Liao W, Huang C, Hsu CY, Chen H, Wu T, Ho W, Wu C. Asthma is associated with endometriosis: A retrospective population-based cohort study. Respir Med. 2017;132:112-6. doi: 10.1016/j.rmed.2017.10.004.
Shi JL, Zheng ZM, Chen M, Shen HH, Li MQ, Shao J. IL-17: An important pathogenic factor in endometriosis. Int J Med Sci. 2022;19(4):769-78. doi: 10.7150/ijms.71972.